# ResMed Inc. (RMD) FY2027 Q1 Revenue by Business Segment by Geography

- Company: ResMed Inc. (RMD)
- Statement: ResMed Inc. (RMD) FY2027 Q1 P&L / Income Statement, https://plicit.ai/financials/rmd/fy2027-q1-income-statement
- Period: 2026-07-01 to 2026-09-30
- Filing: Q1 FY2027 10-Q, filed 2026-10-30, accession number 0000943819-26-000089
- Page: https://plicit.ai/financials/rmd/fy2027-q1-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/rmd-fy2027-q1-revenue-by-business-segment-by-geography-sankey.png

## Chart details: Revenue by Business Segment by Geography

Income statement for 2026-07-01 through 2026-09-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenue**: 1,414,814,000 US dollars
- **Cost of sales**: 544,247,000 US dollars
- **Gross profit**: 870,567,000 US dollars
- **Total operating expenses**: 417,583,000 US dollars
- **Income from operations**: 452,984,000 US dollars
- **Total other income (loss), net**: 86,171,000 US dollars
- **Income before income taxes**: 539,155,000 US dollars
- **Income taxes**: 120,742,000 US dollars
- **Net income**: 418,413,000 US dollars
- **Residential Care Software**: 155,012,000 US dollars
- **Sleep and Breathing Health - Rest of World**: 426,383,000 US dollars
- **Sleep and Breathing Health - Americas**: 833,419,000 US dollars
- **Total operating expenses**: 417,583,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Key Takeaways

- Americas sales rose $58.67 M, while Residential Care Software fell $11.12 M.
- Both Sleep and Breathing Health regions grew 8%, with the Americas adding most of the dollars.
- Americas brought in 59% of total sales this quarter, against 30% for Rest of World.
- Residential Care Software is the only piece shrinking, down 7% while sales grew 6%.
- Americas accounts for 66% of Sleep and Breathing Health sales, against 34% from Rest of World.

## The Unvarnished Truth

### Sleep and Breathing Health's Americas sales supplied 74% of sales growth.

Sleep and Breathing Health's Americas sales supplied 74% of this quarter's net sales growth, a $58.67 M gain out of a $79.23 M total. Residential Care Software fell $11.12 M in the same period, so the total leaned on one region of one business. Even the growth was partly offset by lower life support device sales, which the filing ties to the planned discontinuation of the Astral device. Americas sales of Sleep and Breathing Health rose 8% from a year earlier.

Management's account is about demand: the increase in Americas devices and masks was primarily attributable to increased demand and unit sales. Rest of World grew 8% in constant currency too, which the filing ties partly to device fleet renewals in France. Currency is not the story here, since the filing says movements in international currencies had a negligible impact on Sleep and Breathing Health net revenue. Americas made up 59% of total sales, against 30% for Rest of World.

Put together, the Americas carries the quarter, and its growth rests on demand the filing describes without a single unit count. What it means for a reader is concentration: one region of one business carries most of the growth. Americas sales of $833.42 M are 59% of the company's total, and Rest of World sales of $426.38 M make up 30%. Will the Americas keep carrying the growth, or does its share fall back when the current demand levels off?

## Intelligent Insights for Investors

### What is inside the biggest piece of ResMed's sales?

Sleep and Breathing Health is the biggest piece: its products brought in 89% of sales this quarter, and Americas made up 66% of them. Rest of World made up the other 34%.

### What drove the change in ResMed's biggest business over the past year?

Mostly Americas: it added $58.67 M of the $90.36 M rise in revenue from Sleep and Breathing Health over the year. That is 65% of the group's growth.

## Intelligent Insights for Lenders

### How much does ResMed depend on its biggest piece of sales?

Heavily: Sleep and Breathing Health in the Americas brought in 59% of total sales this quarter, against 30% for its Rest of World sales, the next largest. A slowdown in that one region would hit most of the company's sales.

## Intelligent Insights for Employees

### Which part of sales by region grew fastest over the past year?

Both Sleep and Breathing Health regions grew 8%, against 6% for total sales. Rest of World sales rose $31.69 M, to $426.38 M.
